Something went wrong

We encountered an unexpected error, we encourage you to try again later.

We're here to help

Should you have additional questions please contact PfizerPro customer service.

Representatives are available:
Monday-Friday 8:00am to 9:00pm Eastern time

Call 1 (800) 505-4426

PP-UNP-USA-5796
Order samples Unable to confirm your eligibility

Unfortunately, your registration is incomplete and we are unable to confirm your eligibility for sample ordering.

To gain access please enter your professional information within your account.

Open your account
We're here to help

Should you need further support updating your account information, please contact PfizerPro customer service.

Representatives are available:
Monday-Friday 8:00am to 9:00pm Eastern time

Call 1 (800) 505-4426

​​​​​​​PP-UNP-USA-5796
Order samples
Thank you for expressing interest in Pfizer samples. Currently there are no samples available to order. Samples renew periodically, we encourage you to check back soon.
We're here to help

Should you have additional questions please contact PfizerPro customer service.

Representatives are available:
Monday-Friday 8:00am to 9:00pm Eastern time

Call 1 (800) 505-4426

​​​​​​​PP-UNP-USA-5796
Order samples

All samples available online to you are included below. Availability is updated periodically.

PP-UNP-USA-5796
Important Notice

Savings cards will be shipped with Product Samples, if applicable.

Signature

Use your mouse, finger, or stylus to sign below.

Legal Notice

I certify that I am a licensed prescriber, eligible to request and receive the drug samples listed in the quantities indicated. I am also confirming that these samples will be used exclusively for the medical treatment of my patients in conformity with all relevant state and/or local prescribing and dispensing requirements. My signature will also serve as confirmation of my receipt of these medications, if delivered by a company representative, or my intention to acknowledge them upon delivery to my medical office if shipped via common carrier. I understand that these samples cannot be sold, traded, bartered returned for credit or utilized to seek or obtain reimbursement.

Your order has been placed

We have received your order and are getting it ready

More to explore Patient assistance

Download available co-pay cards and patient savings offers across select Pfizer products.

Explore patient assistance Loading
Vaccines

Find out more about the diseases, treatments and prevention methods that are impacted by our Pfizer Vaccine portfolio.

Explore Vaccines Loading
PP-UNP-USA-5796
Leave ordering?

Changes you have made will not be saved.

This site is intended for U.S. healthcare professionals.

For patient resources and support click HERE

Menu

Close

Sign InLog OutTherapy AreasProductsOrder VaccinesOrder SamplesOrderMaterialsCo-pay Cards & Patient Savings OffersRequest SamplesHospital ProductsVaccinesPatient AssistancePfizer Oncology TogetherPfizer RxPathwaysPfizer Dermatology Patient AccessExplore ContentEventsMaterialsVideosContact
Search

Menu

Close

HomeCOVID-19 ImpactCOVID-19
Impact 
Burden of DiseaseUMCs & Risk FactorsDiscussing Vaccination
About COMIRNATYAbout COMIRNATYIntroductionmRNA TechnologyCOMIRNATY Clinical Trial OverviewCOMIRNATY Pivotal TrialSelect Safety DataRCTs & RWERandomized Controlled Trials & Real-World EvidenceRCTs and RWE Considerations24-25 Appaneal Study Design24-25 Appaneal VE AnalysisDosingDosing & AdministrationIntroduction & FAQsCOMIRNATY Dosing for ≥12 YearsCOMIRNATY Dosing for 5-11 YearsPatient ProfilesPatient
ProfilesHypothetical Patient ProfilesSusan is 68 years oldClaire has chronic kidney diseaseMike has asthmaHypothetical Patient ProfilesSusan is 68 years oldClaire has chronic kidney diseaseMike has asthmaMaria has coronary artery diseaseTom has type 2 diabetesMaria has coronary artery diseaseTom has type 2 diabetesResourcesResourcesLinks & SupportCOMIRNATY Health Plan CoverageMaterialsHypothetical Patient ProfilesSusan is 68 years oldMike has asthmaMaria has coronary artery diseaseTom has type 2 diabetes
IndicationPrescribing InformationPatient InformationPatient SiteOrder on Pfizer PrimePediatric Information (5 years & older)
Dosing and administration

Introduction & FAQs

COMIRNATY Dosing
for ≥12 Years

COMIRNATY Dosing
for 5-11 Years

Tab Number 4

Tab Number 5

Introduction & FAQs

COMIRNATY comes in 2 age-appropriate dosing presentations

  • COMIRNATY single-dose glass prefilled syringes (labeled with gray borders) for individuals 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19, and for individuals 65 years of age and older
  • COMIRNATY single-dose vials (blue caps and labeled with blue borders) for individuals 5 through 11 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19

12-month refrigerated storage

for COMIRNATY prefilled syringes1,2*

12-month refrigerated storage

for COMIRNATY prefilled syringes1,2*

COMIRNATY

prefilled syringes are a well-stocked COVID-19
vaccine3-5†

COMIRNATY

prefilled syringes are a well-stocked COVID-19 vaccine3-5†

When stored at 2ºC to 8ºC (35ºF to 46ºF). DO NOT FREEZE. Not to exceed the expiration date printed on the carton and syringe labels.1,2Inclusive of administered COVID-19 vaccine doses in individuals ≥12 years in the US from September 2025 through May 2026.4Quick Links Prefilled syringe

Available for eligible individuals 12 years of age and older.1

View dosing information
Loading
Single-dose vial

Available for eligible individuals 5-11 years of age.1

View dosing information
Loading
COMIRNATY FAQsWhat is required for COMIRNATY storage?

There are two dosing presentations for COMIRNATY:​

For eligible individuals ≥12 years, COMIRNATY prefilled syringes are refrigerator stable at 2°C to 8°C (35°F to 46°F) for 1 year from date of manufacture to the expiration date printed on the carton and the syringe labels.1,2​

For eligible individuals aged 5-11 years, COMIRNATY single-dose vials can be kept in a ULT freezer (-90ºC to -60ºC [-130ºF to -76ºF]) for up to 18 months. If vial is frozen, thaw vial in the refrigerator (2°C to 8°C [35°F to 46°F] for up to 2 hours) or at room temperature (up to 25°C [77°F] for 30 minutes). Once thawed, it can be refrigerated (2°C to 8°C [35°F to 46°F]) for up to 10 weeks.​1,6​

See full dosing for ≥12 years here and 5-11 years here.​

What is the COMIRNATY shelf life?

For eligible individuals ≥12 years, COMIRNATY prefilled syringes are refrigerator stable for 1 year from date of manufacture to the expiration date printed on the carton and the syringe labels.1,2

For eligible individuals aged 5-11 years, COMIRNATY single-dose vials can be kept in ULT storage for up to 18 months and are good refrigerated for up to 10 weeks.1,6​

See full dosing for ≥12 years here and 5-11 years here.

How long can COMIRNATY be out of the fridge?

COMIRNATY prefilled syringes (for eligible individuals ≥12 years) must not exceed 12 hours out of refrigeration at 8ºC to 25ºC (46ºF to 77ºF).1‡§

Once thawed, COMIRNATY single-dose vials (for eligible individuals 5-11 years) must not exceed 12 hours out of refrigeration at 8ºC to 25ºC (46ºF to 77ºF).1‡||

See full dosing for ≥12 years here and 5-11 years here.

Regardless of presentation, during storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light.1Do not shake. Remove tip cap by slowly turning the cap counterclockwise while holding the Luer lock and attach a sterile needle. Use immediately. If COMIRNATY cannot be used immediately, it must be used within 4 hours.1Do not refreeze thawed vials.1
What is the COMIRNATY expiration date?

For eligible individuals ≥12 years, COMIRNATY prefilled syringes expire 1 year from the date of manufacture, on the date printed on the carton and the syringe labels.1,2

For eligible individuals aged 5-11 years, COMIRNATY single-dose vials, 10-week refrigerated expiry date should be recorded on the carton at the time of transfer. Cartons of 10 single-dose vials may take up to 2 hours to thaw at this temperature. Once thawed, they should not be refrozen.1,6

See full dosing for ≥12 years here and 5-11 years here.

< Back Real-World Evidence Loading
Up next >
COMIRNATY for ≥12 Years Loading
ULT=ultra-low temperature.
COMIRNATY Dosing and Administration (≥12 Years)

Prefilled syringes are available for those1:

  • 65 years of age and older, or
  • 12-64 years of age with at least 1 underlying condition that puts them at high risk for severe outcomes from COVID-19

12-month refrigerated storage for COMIRNATY prefilled syringes1,2*When stored at 2ºC to 8ºC (35ºF to 46ºF). DO NOT FREEZE. Not to exceed the expiration date printed on the carton and syringe labels.1,2

 
COMIRNATY for ≥12 years
Single-dose glass prefilled syringe • DO NOT FREEZE1
Approved use1
  • 65 years of age and older, or
  • 12-64 years of age with at least 1 underlying condition that puts them at high risk for severe outcomes from
      COVID-19
Verify syringe label1
Dose1 30 mcg
Dose volume1 0.3 mL

 

COMIRNATY for ≥12 years
Single-dose glass prefilled syringe • DO NOT FREEZE1
Approved use1
  • 65 years of age and older, or
  • 12-64 years of age with at least 1 underlying condition that puts them at high risk for severe outcomes from COVID-19
Verify syringe label1
Dose1 30 mcg
Dose volume1 0.3 mL
Storage conditions: prefilled syringes
Total time out of refrigeration1 The total time out of refrigeration (at temperatures between 8°C and 25°C (46°F and 77°F) must not exceed 12 hours
Refrigerator stable for up to 12 months1,2 DO NOT FREEZE. COMIRNATY prefilled syringes are refrigerator stable at 2°C to 8°C (35°F to 46°F). Do not use the vaccine after the expiration date printed on the prefilled syringes and cartons
COMIRNATY Administration (≥12 Years)1

Single-dose prefilled syringes 

For additional information, please see Full Prescribing Information and Patient Information.

Step 1: Verify

  • Verify that the label on the prefilled syringe states the correct Formula year
  • Glass prefilled syringes are supplied in a carton containing 10 syringes
  • Single-dose syringes for individuals 12 years and older are labeled with gray borders
  • If prefilled syringe has been frozen, discard

    Step 2: Prepare

    • Do not shake
    • Remove tip cap by slowly turning the cap counterclockwise while holding the Luer lock, and attach a sterile needle
    • Use immediately. If COMIRNATY cannot be used immediately after cap is removed, it must be used within 4 hours

    Step 3: Inspect

    • Inspect prefilled syringes for particulate matter and discoloration prior to administration​
    • The vaccine will be a white to off-white suspension​
    • Do not administer if vaccine is discolored or contains particulate matter

    Step 4: Administer

    • For the prefilled syringe, intramuscularly administer the entire volume to deliver a single 0.3-mL dose​
    • For individuals previously vaccinated with any COVID-19 vaccine, administer the dose of COMIRNATY at least 2 months after the last dose of a COVID-19 vaccine
    < Back
    Introduction & FAQs
    Loading
    Up next >
    COMIRNATY for 5-11 Years
    Loading
    COMIRNATY Dosing and Administration 
    (5-11 Years)
    *

    With at least 1 UMC that puts them at high risk for severe outcomes from COVID-19.1

    COMIRNATY Product Verification and Dosing
    Ages 5-11 Years 

     

    Storage conditions: single-dose vials
    Approved use1 5-11 years of age with at least 1 underlying condition than puts them at high risk for severe outcomes from COVID-19
    Verify syringe label1 Confirm product is in vial with blue cap with blue borders
    Dose1 10 mcg
    Dose volume1 0.3 mL

     

    COMIRNATY for 5-11 years
    Single-dose vial • DO NOT REFREEZE THAWED VIALS1
    Approved use1 5-11 years of age with at least 1 underlying condition that puts them at high risk for severe outcomes from COVID-19
    Verify syringe label1 Confirm product is in vial with blue cap with blue borders
    Dose1 10 mcg
    Dose volume1 0.3 mL
    Scroll left to view table
    COMIRNATY Storage Conditions Ages 5-11 Years 
    Scroll left to view table
    Scroll left to view table
    Storage conditions: single-dose vials
    Total time out of refrigeration1 The total time out of refrigeration (at temperatures between 8°C and 25°C [46°F and 77°F]) must not exceed 12 hours
    Refrigerator1 10 weeks
    • The 10-week refrigerated expiry date should be recorded on the carton at the time of transfer
    • Once thawed, the vials should not be refrozen
    Ultra-low temperature (ULT) freezer1,6 18 months storage in a ULT freezer (-90°C to -60ºC [-130ºF to -76ºF])
    COMIRNATY Administration (5-11 Years)Single-dose vials

    For additional information, please see Full Prescribing Information and Patient Information.

    Step 1: Verify

    DO NOT DILUTE

    COMIRNATY is a suspension for injection, for intramuscular use only.

    During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light.

    • Single-dose vials for eligible individuals 5 through 11 years of age have blue caps and labels with blue borders
    • Blue cap vials are supplied in a carton of 10 singIe-dose vials
    • Each single-dose vial contains 1 dose of 0.3 mL (no dilution required)

    Step 2: Confirm Formula and Thaw Vials

    • Verify that the label on the vial states the correct Formula year
    • Take out of refrigerator or thaw
    • If vial is frozen, thaw vial in the refrigerator (2ºC to 8ºC [35ºF to 46ºF] for up to 2 hours) or at room temperature (up to 25ºC [77ºF] for 30 minutes)

    Step 3: Preparation

    • Prior to use, mix by inverting vial gently 10 times. Do not shake
    • Withdraw a single 0.3-mL dose using a sterile needle and syringe
    • Discard vial and any excess volume

    Step 4: Administer

    • COMIRNATY is administered as a single dose
    • Visually inspect for particulate matter and discoloration prior to administration
    • The vaccine will be a clear to slightly opalescent suspension
    • Do not administer if vaccine is discolored or contains particulate matter
    • Administer the 0.3-mL dose intramuscularly immediately after preparation
    • For individuals previously vaccinated with any COVID-19 vaccine, administer the dose of COMIRNATY at least 2 months after the last dose of a COVID-19 vaccine
    < Back
    COMIRNATY for ≥12 Years
    Loading
    Up next >
    Hypothetical Patient Profiles
    Loading
    Ordering available through Pfizer Prime*

    Orders for 2024-2025 formula COVID-19 vaccines by BioNTech and Pfizer can be placed by eligible healthcare professionals directly with Pfizer through Pfizer Prime online or by calling 1-800-533-4535.

    Button Loading

    Optional footnote area for disclaimers etc.

    Ordering available through Pfizer Prime*Orders for 2024-2025 formula COVID-19 vaccines by BioNTech and Pfizer can be placed by eligible healthcare professionals directly with Pfizer through Pfizer Prime online or by calling 1-800-533-4535. Visit Pfizer Prime LoadingLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.ReferencesLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur neque tellus, elementum sit amet lectus id, congue varius elit. Fusce molestie urna id elit fermentum tincidunt. Proin vel nibh sed elit commodo efficitur nec nec ipsum. Aliquam erat volutpat. Suspendisse eu elit et nisi malesuada luctus. Phasellus nec velit dapibus, condimentum purus non, rutrum mi. In eros sem, pellentesque id congue mollis, vehicula sit amet neque. Quisque condimentum feugiat quam non rhoncus. Cras eget vestibulum urna. Nullam sodales ipsum elit, ac commodo odio fringilla at.

    Eligible healthcare providers can order COVID-19 vaccines directly from Pfizer. If preferred, orders may be placed with your facility’s wholesaler.

    References:COMIRNATY® (COVID-19 Vaccine, mRNA). Prescribing Information. BioNTech Manufacturing GmbH and Pfizer Inc.; August 27, 2026.Data on file. Pfizer, Inc.; April 18, 2025.Data on file. Pfizer, Inc.; January 12, 2026.Data on file. Pfizer, Inc.; June 11, 2026.Data on file. Pfizer, Inc.; August 28, 2024.Data on file. Pfizer, Inc.; June 7, 2025.
    Dosing and administration

    Manufactured for
    BioNTech Manufacturing GmbH
    An der Goldgrube 12
    55131 Mainz, Germany
    Marketing Authorization Holder 

    Manufactured by
    Pfizer Inc.
    New York, NY 10001

    The formulation of COMIRNATY, which is based on BioNTech proprietary mRNA technology, was developed by BioNTech and Pfizer.  

    The formulation of COMIRNATY, which is based on BioNTech proprietary mRNA technology, was developed by BioNTech and Pfizer.  

    To report an adverse event, please call 1-800-438-1985

    Pfizer for Professionals 1-800-505-4426

    This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

    © 2026 Pfizer Inc. All rights reserved.

    PP-CMR-USA-0468
    You are now leaving PfizerPro

    You are now leaving a Pfizer-operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.

    PP-MCL-USA-0367

    INDICATION
    COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

    COMIRNATY is approved for use in individuals who are:
    • 65 years of age and older, or
    • 5 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.
    Important Safety InformationDo not administer COMIRNATY® (COVID-19 Vaccine, mRNA) to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of COMIRNATY or to individuals who had a severe allergic reaction (e.g., anaphylaxis) following a previous dose of a Pfizer-BioNTech COVID-19 vaccine.Management of Acute Allergic ReactionsAppropriate medical treatment must be immediately available to manage potential anaphylactic reactions following administration of COMIRNATY.

    Myocarditis and Pericarditis

    Postmarketing data from use of authorized or approved mRNA COVID-19 vaccines, including COMIRNATY, have demonstrated increased risks of myocarditis and pericarditis, with onset of symptoms typically in the first week following vaccination. The observed risk has been highest in males 12 years through 24 years of age.

    SyncopeSyncope (fainting) may occur in association with administration of injectable vaccines, including COMIRNATY. Procedures should be in place to avoid injury from fainting.Altered ImmunocompetenceImmunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to COMIRNATY.Limitation of Vaccine EffectivenessCOMIRNATY may not protect all vaccine recipients.Adverse ReactionsMost commonly reported adverse reactions after a dose:
    • 12 years of age and older (≥10%) were pain at the injection site (up to 90.5%), fatigue (up to 77.5%), headache (up to 75.5%), chills (up to 49.2%), muscle pain (up to 45.5%), joint pain (up to 27.5%), fever (up to 24.3%), injection site swelling (up to 11.8%), and injection site redness (up to 10.4%).
    • 5 years through 11 years of age (≥5%) were pain at the injection site (up to 83.8%), fatigue (up to 51.9%), headache (up to 38.4%), injection site redness (up to 25.9%), injection site swelling (up to 20%), muscle pain (up to 18.1%), chills (up to 13.3%), fever (up to 7.8%), and joint pain (up to 7.6%).
    To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985
    or https:/www.pfizersafetyreporting.com or VAERS at 1-800-822-7967 or https://vaers.hhs.gov
    Please click for COMIRNATY Full Prescribing Information and Patient Information. Indication
    COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

    COMIRNATY is approved for use in individuals who are:
    • 65 years of age and older, or
    • 5 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.